Mauna Kea’s Cellvizio Confocal Laser Endomicroscopy Cleared in U.S. for Neurological Procedures

June 1st, 2018 Editors Neurosurgery, Pathology

Mauna Kea‘s (Paris, France) Cellvizio 100 series F400 and F800, with a new Confocal Miniprobe called CranioFle, has been granted FDA clearance to be used in neurological procedures targeting brain and spinal tumors.

The confocal laser endomicroscopy system allows clinicians to analyze the cellular structure and characteristics of tissues right in the operating room.

The system relies on a variety of reusable probes that integrate a scanning laser and a detector that images the tissue. The probes can be delivered through an endoscope, the tip of which is placed against the tissue of interest. Images are immediately displayed in real-time on the system’s screen and the probe can be moved against the tissue to analyze different areas in a single procedure.

“This is an important regulatory and business milestone for the Company, opening new avenues for market development and strategic partnerships,” in a statement said Sacha Loiseau, Ph.D., Founder and CEO of Mauna Kea Technologies. “It also unlocks a new era in neurosurgery, paving the way toward more precise resection of brain and spinal tumors. Cellvizio^®is now the first to market endomicroscopic visualization platform providing neurosurgeons for the first time the ability to perform real-time optical biopsies to help determine, for instance, if the tumor is completely excised. This clearance builds on many years of clinical development and is happening at a time when the neurosurgery community recognizes the potential benefits of real-time digital visualization of nervous system tissue microstructures.”

Flashbacks: Mauna Kea’s Cellvizio Confocal Laser Endomicroscopy Released Through Cook Medical…; Endo-microscopy from Mauna Kea Technologies…; Mauna Kea AQ-Flex 19 Miniprobe for Optical GI Biopsies…; Endo-microscopy from Mauna Kea Technologies…; Mauna Kea UroFlex Optical Biopsy Probe Cleared in Europe…; Endo-microscopy Technique Shows Promise for Early Colon CA Diagnosis…; Cellvizio 100 Series Endomicroscopy System Obtains 510(k) Clearance from FDA…

Product page: Cellvizio…

Via: Mauna Kea…

Upcoming conferences

october

18octallday19alldayWorld Congress on Polycystic Ovarian Syndrome and Fertility, 2018Abu Dhabi, UAE

18octallday19alldayManaging Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an InspectionMinneapolis, MN, USA

Event Details

Post-Market activities, Complaint Handling, MDRs, and Recalls are expensive, time consuming, and often lead to more serious financial consequences. Over 80% of FDA Inspection target observations for lack of compliance in these areas.

By attending this seminar, you will discover:

How to overcome one of the biggest obstacles device manufacturers face
How the FDA expects you to develop and implement proper handling of complaints reportable or non-reportable, product complaint handling and documentation
How and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall.
How to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.

**New course materials have been added, updated content will include:

Creating Standard Operating Systems (SOPs) for Post-Market Quality Systems and
What to expect from the changes in ORA with Inspection Structure Realignment

This Seminar will have you stop spinning your wheels with nonessential activities, and leave you with a comprehensive learning package that only Rita Hoffman, a former FDA CDRH Recall Branch Chief with experience across the device, drug and veterinary industries can provide.

Spend one and a half days in an interactive course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief with over 36 years with FDA and leading Industry Expert, who will provide the participants with tools to minimize risk of regulatory enforcement actions.

Time

october 18 (Thursday) - 19 (Friday)

Organizer

Compliance Online 80068SEM

Learn More

Calendar GoogleCal

18octallday19allday18th Global Ophthalmology, Optometry and Glaucoma Conference, 2018Helsinki, Finland

18octallday19alldayBiology and Pathology of Infectious Disease Conference, 2018Helsinki, Finland

18octallday19allday14th Global Biomarkers Summit, 2018Amsterdam, Netherlands

22octallday23alldayInternational Conference on Breast Cancer, 2013Vancouver, British Columbia, Canada